EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Ann H Partridge, Samuel M Niman, Monica Ruggeri, Fedro A Peccatori iD, Hatem A Azim, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna B Sætersdal, Judith R Kroep, Audrey Mailliez, Ellen Warner und 29 weitere

New England Journal of Medicine · 04.05.2023 · 388 (18) · 1645-1656

DOI: 10.1056/nejmoa2212856 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift New England Journal of Medicine, erschienen am 04.05.2023. Verfasst von Ann H Partridge und 40 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Medical Oncology, Dana-Farber Cancer Institute (A.H.P.), Harvard Medical School (A.H.P., R.D.G.), the International Breast Can…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 236-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, ETOP IBCSG Partners Foundation, Alliance for Clinical Trials in Oncology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAdultFemaleHumansPregnancyAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyDisease-Free SurvivalNeoplasm Recurrence, LocalProspective StudiesWithholding Treatment

Autor:innen und Institutionen

  • From the Department of Medical Oncology, Dana-Farber Cancer Institute (A.H.P.), Harvard Medical School (A.H.P., R.D.G.), the International Breast Cancer Study Group Statistical Center and the Department of Data Science,…

ORCID-Profile: Fedro A Peccatori, Akemi Kataoka, Karin Ribi

Förderung

  • NCI NIH HHS
  • ETOP IBCSG Partners Foundation
  • Alliance for Clinical Trials in Oncology

Zitieren

APA

Partridge, A. H., Niman, S. M., Ruggeri, M., Peccatori, F. A., Azim, H. A., Colleoni, M., Saura, C., Shimizu, C., Sætersdal, A. B., Kroep, J. R., Mailliez, A., Warner, E., Borges, V. F., Amant, F., Gombos, A., Kataoka, A., Rousset-Jablonski, C., Borstnar, S., Takei, J., …, & POSITIVE Trial Collaborators (2023). Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer. New England Journal of Medicine, 388(18), 1645-1656. https://doi.org/10.1056/nejmoa2212856

Vancouver

Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, et al. Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer. New England Journal of Medicine. 2023;388(18):1645-1656. doi:10.1056/nejmoa2212856

BibTeX
@article{Partridge2023,
  author = {Partridge, Ann H and Niman, Samuel M and Ruggeri, Monica and Peccatori, Fedro A and Azim, Hatem A and Colleoni, Marco and Saura, Cristina and Shimizu, Chikako and Sætersdal, Anna B and Kroep, Judith R and Mailliez, Audrey and Warner, Ellen and Borges, Virginia F and Amant, Frédéric and Gombos, Andrea and Kataoka, Akemi and Rousset-Jablonski, Christine and Borstnar, Simona and Takei, Junko and Lee, Jeong E and Walshe, Janice M and Ruíz-Borrego, Manuel and Moore, Halle C F and Saunders, Christobel and Bjelic-Radisic, Vesna and Susnjar, Snezana and Cardoso, Fatima and Smith, Karen L and Ferreiro, Teresa and Ribi, Karin and Ruddy, Kathryn and Kammler, Roswitha and El-Abed, Sarra and Viale, Giuseppe and Piccart, Martine and Korde, Larissa A and Goldhirsch, Aron and Gelber, Richard D and Pagani, Olivia and International Breast Cancer Study Group, International Breast Cancer Study Group and POSITIVE Trial Collaborators, POSITIVE Trial Collaborators},
  title = {Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {18},
  pages = {1645--1656},
  doi = {10.1056/nejmoa2212856}
}
Kostenlos starten →